Advice about safely opening and dispersing the contents of fluoxetine capsule products can be found in the Society of Hospital Pharmacists (SHPA) guidelines Patients with swallowing difficulties, dexterity issues, health conditions requiring enteral feeding or other conditions where the capsule dose form is not appropriate will require individualised advice regarding treatment options In the event that a patient cannot receive their prescribed dose, referral to a prescriber would be required Aside from creating an MSAG, the TGA has also made a Serious Scarcity Substitution Instrument (SSSI) that allows pharmacists to dispense the 20 mg and 10 mg capsule alternatives as needed without first being approved by the prescriber
Finally, studies should be carried out on the potential toxicity of the drug, and more attention must be paid to possible side effects (sometimes the simplest ones, such as weight loss, increase/decrease in body temperature, etc.) that may occur when the substance is used in a given disease model
Rarely, persistent symptoms point to an underlying condition unrelated to semaglutide, which is why clinical oversight matters
Blood 70, 791795 [PubMed] [Google Scholar] Teegen B., Niemann S., Probst C., Schlumberger W., Stocker W., Komorowski L
Weeks 2 to 3: More consistent hunger reduction, possible taste changes, improved meal satisfaction from smaller portions
The study evaluated patients after nine weeks of treatment with cisplatin alone or with cisplatin and glutathione
